Calcium blockers for heart disease: two approved, more to come

JAMA. 1982;247(14):1911-1917. doi:10.1001/jama.1982.03320390005003.
Text Size: A A A
Published online


Calcium-entry blockers, a class of drugs that increase the heart's blood supply by reducing the spontaneous constriction of cardiac and arterial muscle cells, are finally becoming available for the struggle against heart disease.

The Food and Drug Administration has now approved two of these agents, nifedipine and verapamil, for use orally in the treatment of angina pectoris. One other, diltiazem hydrochloride, is expected to receive FDA approval soon for the same purpose. All three drugs have been used for years in other countries (JAMA [MEDICAL NEWS] 1981;245:807/X 816). The intravenous (IV) form of verapamil was approved in August 1981 for the treatment of some arrhythmias.

Calcium-entry blockers interfere with the mechanism of smooth muscle contraction in the arterial walls. This contraction process is triggered by the entrance of extracellular calcium ions into the muscle cells. The drugs thus can be expected to prevent angina attacks in which arterial spasm plays


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.